Nephros vs QT Imaging Holdings
QT Imaging Holdings reported revenue of $19 million in fiscal 2025, about the same as Nephros' $19 million in fiscal 2025. Nephros' revenue grew 32.7% in its latest year, and QT Imaging Holdings' grew 287.9%. Nephros had an operating margin of 6.1%, against -23.4% at QT Imaging Holdings.
Side by side
| Nephros | QT Imaging Holdings | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $19M | $19M |
| Revenue growth | 32.7% | 287.9% |
| Revenue growth a year, last 5 years | 16.9% | — |
| Gross margin | 61.9% | 45.4% |
| Operating margin | 6.1% | −23.4% |
| Net margin | 6.3% | −111.4% |
| Free cash flow | — | −$9M |
| Free cash flow margin | — | −48.0% |
| Return on capital | — | −130.7% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 3.5% | 57.3% |
| Last close | $2.84 | $1.87 |
| P/E at the last close | 15.8× | — |
| Insider trades, last 12 months | bought $22,075, sold $0 | bought $155,008, sold $0 |
| Piotroski F-score | — | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
NephrosQT Imaging Holdings
Operating margin
Percent of revenue
NephrosQT Imaging Holdings
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
NephrosQT Imaging Holdings
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Nephros and QT Imaging Holdings pages.